If left untreated, it can advance to liver fibrosis, cirrhosis, and liver failure
Understanding their mechanisms, benefits, and associated risks will remain essential as their role in clinical medicine continues to expand
A Sanofi spokesperson told BioSpace in an emailed statement that the company made the strategic decision of focusing on offering the combination therapy Soliqua consisting of GLP-1 and basal insulin to help people manage their diabetes. The spokesperson added that Soliqua has since become one of the cornerstone therapies in its diabetes portfolio and represents an important growth asset for the company
In general, the industry continues to be in a healthy position and future forecasts are promising, according to Mr
Mounjaro: type 2 diabetes, off-label weight loss
Shrimp & Zucchini Noodles (26g protein) Light, fresh, and high in protein without feeling heavy